Pubmed- Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-alpha) Agents in Crohn's Disease - IBD Reporter Newsfeed - IBD Support Group Forums - IBDsupport.org

Advertisement

Jump to content


Photo
- - - - -

Pubmed- Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-alpha) Agents in Crohn's Disease


  • Please log in to reply
No replies to this topic

#1 Health Reporter

Health Reporter

    Newsfeeder

  • RSS
  • PipPipPipPip
  • 20753 posts
  • Country:United States

Posted 07 June 2021 - 01:48 PM

Advertisement

Cureus. 2021 Apr 30;13(4):e14768. doi: 10.7759/cureus.14768.

ABSTRACT

Crohn's disease patients experience a higher rate of postoperative complications than do general surgical patients. The use of anti-tumor necrosis factor-alpha (anti-TNF-α) therapy in the treatment of severe Crohn's disease and other autoimmune inflammatory conditions is increasing and expanding. We describe the case of a 47-year-old female Crohn's patient who experienced two rare and serious adverse effects of anti-TNF-α therapy following laparoscopic ileocectomy for obstructive Crohn's disease. On the first postoperative day, the patient developed intra-abdominal hemorrhage requiring transfusion and emergency abdominal exploration. Findings were consistent with a rare hemorrhagic complication of her anti-TNF-α medication. She recovered and was ultimately discharged from the hospital without further complications. Less than 24 hours following discharge, the patient suffered two grand mal seizures. Imaging demonstrated white matter demyelination of the brain. The patient recovered, again, with no clinical sequelae. These two dangerous events are known to rarely be associated with the use of such biologic agents. We review both the therapeutic actions of these medications and the theorized etiologies for these two rare adverse events. Ultimately, this patient's complications should serve as a cautionary tale in the use of such therapeutics, as well as a reminder of the risks associated with anti-TNF-α use.

PMID:34094733 | PMC:PMC8164735 | DOI:10.7759/cureus.14768


View the full article


Advertisement




© Copyright 1995-2014 IBD Support All rights reserved.

About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service | Crisis Resources

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here